Correlation of clinical and neurophysiological findings with health-related quality of life in patients with diabetic polyneuropathy;Korelacija kliničkih i neurofizioloških nalaza sa kvalitetom života bolesnika sa dijabetesnom polineuropatijom

Vojnosanitetski Pregled

Volumn 71, Issue 9, 2014, Pages 833-838

  Vukojević, Zoran ^a   Pekmezović, Tatjana ^b   Nikolić, Ana ^b   Perić, Stojan ^b   Basta, Ivana ^b   Marjanović, Ivan ^b   Lavrnić, Dragana ^b  

^a Clinical Center Banja Luka   (Bosnia and Herzegovina)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Diabetic neuropathies; Neurophysiology; Quality of life; Questionnaires

Indexed keywords

ACTION POTENTIAL AMPLITUDE; ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; DIABETIC NEUROPATHY; DISABILITY SCALE; ELECTRONEUROGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HAMILTON ANXIETY SCALE; HUMAN; INFLAMMATORY NEUROPATHY CAUSE AND TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH COUNCIL STRENTH SCORE; MOTOR NERVE CONDUCTION; MUSCLE ACTION POTENTIAL; NEUROPHYSIOLOGICAL MONITORING; QUALITY OF LIFE; SCORING SYSTEM; SENSORY NERVE CONDUCTION; SHORT FORM 36; HEALTH STATUS INDICATOR; MEDIAN NERVE; MIDDLE AGED; NERVE CONDUCTION; PATHOPHYSIOLOGY; QUESTIONNAIRE;

ADULT; DIABETIC NEUROPATHIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MEDIAN NERVE; MIDDLE AGED; NEURAL CONDUCTION; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84929910603     PISSN: 00428450     EISSN: 24060720     Source Type: Journal    
DOI: 10.2298/VSP120919015V     Document Type: Article

References (33)

1. Report and recommendations of the San Antonio conference on diabetic neuropathy. Neurology 1988; 38(7): 1161-5.
2. Vinik A, Ullal J, Parson HK, Casellini CM. Diabetic neuropathies: clinical manifestations and current treatment options. Nat Clin Pract Endocrinol Metab 2006; 2(5): 269-81.
3. Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chap-pell AS. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 2007; 8(Suppl 2): S50-62.
4. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28(4): 956-62.
5. Ziegler D. Painful diabetic neuropathy: treatment and future aspects. Diabetes Metab Res Rev 2008; 24(Suppl 1): 52-7.
6. Gooch CL, Weimer LH. The electrodiagnosis of neuropathy: basic principles and common pitfalls. Neurol Clin 2007; 25(1): 1-28.
7. Dyck PJ, Karnes JL, Brien OP, Litchy WJ, Low PA, Melton LJ. The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology 1992; 42(6): 1164-70.
8. Benbow SJ, Wallymahmed ME, MacFarlane IA. Diabetic peripheral neuropathy and quality of life. QJM 1998; 91(11): 733-7.
9. Wändell PE. Quality of life of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries. Scand J Prim Health Care 2005; 23(2): 68-74.
10. Bosic'-Živanovic D, Medic'-Stojanoska M, Kovacev-Zavisić B. The quality of life in patients with diabetes mellitus type 2. Vojno-sanit Pregl 2012; 69(10): 858-63.
11. Venkataraman K, Wee HL, Leow MK, Tai ES, Lee J, Lim SC, et al. Associations between complications and health-related quality of life in individuals with diabetes. Clin Endocrinol (Oxf) 2013; 78(6): 865-73.
12. daCosta DiBonaventura M, Cappelleri JC, Joshi AV. A longitudinal assessment of painful diabetic peripheral neuropathy on health status, productivity, and health care utilization and cost. Pain Med 2011; 12(1): 118-26.
13. Kleyweg RP, van der Meché FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 1991; 14(11): 1103-9.
14. Merkies IS, Schmitz PI, van der Meché FG, Samijn JP, van Doorn PA. Inflammatory Neuropathy Cause and Treatment (INCAT) group. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 2002; 72(5): 596-601.
15. Merkies IS, Schmitz PI, van der Meché FG, van Doorn PA. Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 2000; 54(4): 943-9.
16. Van Nes SI, Faber CG, Hamers RP, Harschnitz O, Bakkers M, Hermans MC, et al. Revising two-point discrimination assessment in normal aging and in patients with polyneuropathies. J Neurol Neurosurg Psychiatr 2008; 79(7): 832-4.
17. Sharma KR, Saadia D, Facca AG, Resnick S, Ayyar DR Clinical and electromyographic deep tendon reflexes in polyneuropathy: diagnostic value and prevalence. Acta Neurol Scand 2009; 119(4): 224-32.
18. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6(4): 278-96.
19. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32(1): 50-5.
20. Tankisi H, Pugdahl K, Fuglsang-Frederiksen A, Johnsen B, Carvalho M, Fawcett PR, et al Pathophysiology inferred from electrodi-agnostic nerve tests and classification of polyneuropathies. Suggested guidelines. Clin Neurophysiol 2005; 116(7): 1571-80.
21. SF-36 Health Survey (Original version). Language Recalls. Available from: http://www.qualitymetric.com [accessed 2010April 04].
22. Lloyd A, Sawyer W, Hopkinson P. Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health 2001; 4(5): 392-400.
23. Padua L, Saponara G, Ghirlannda G, Aprile R, Padua R, Pauri F. Health-related qualitiy of life in type 1 diabetic patients and influence od peripheral nerve involvement. Neurol Sci 2001; 22(3): 239-45.
24. Wasserman LI, Trifonova EA. Quality of life and structure of neurosis-like symptomatology in persons with insulin-dependent diabetes mellitus. Int J Ment Health 2004; 33(3): 47-57.
25. Smide B, Lukwale J, Msoka A, Wikblad K Self-reported health and glycaemic control in Tanzanian and Swedish diabetic patients. J Adv Nurs 2002; 37(2): 182-91.
26. Merkies IS, Schmitz PI Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients' own clinical judgement in immune-mediated polyneuropathies. J Neurol Neurosurg Psychiatr 2006; 77(8): 970-2.
27. Merkies IS, Schmitz PI, Meché FG, Samijn JP, Doorn PA. Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology 2002; 59(1): 84-91.
28. Yoshida S, Hirai M, Suzuki S, Awata S, Oka Y. Neuropathy is associated with depression independently of health-related quality of life in Japanese patients with diabetes. Psychiatry Clin Neurosci 2009; 63(1): 65-72.
29. Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS, Stacey B. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage 2005; 30(4): 374-85.
30. Hänninen JA, Takala JK, Keinänen-Kiukaanniemi SM. Depression in subjects with type 2 diabetes. Predictive factors and relation to quality of life. Diabetes Care 1999; 22(6): 997-8.
31. Mitsonis C, Dimopoulos N, Psarra V. Clinical implications of anxiety in diabetes. A critical review of the evidence base. Eur Psychiatr 2009; 24(Suppl 1): S526.
32. Ovayolu N, Akarsu E, Madenci E, Torun S, Ucan O, Yilmaz M. Clinical characteristics of patients with diabetic polyneuropathy: the role of clinical and electromyographic evaluation and the effect of the various types on the quality of life. Int J Clin Pract 2008; 62(7): 1019-25.
33. Meijer JW, Lange F, Links TP, Hoeven JH. Muscle fiber conduction abnormalities in early diabetic polyneuropathy. Clin Neurophysiol 2008; 119(6): 1379-84.